Literature DB >> 16571771

IFN-beta-induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia.

Hongwei Qin1, Cynthia A Wilson, Sun Jung Lee, Etty N Benveniste.   

Abstract

Costimulation between T cells and antigen-presenting cells is required for adaptive immune responses. CD40, a costimulatory molecule, is expressed in macrophages and microglia. The aberrant expression of CD40 is involved in human diseases including multiple sclerosis, rheumatoid arthritis, and Alzheimer's disease. CD40 expression is induced by a variety of stimuli, including IFN-gamma and lipopolysaccharide (LPS). In this study, we describe the molecular basis by which IFN-beta, a cytokine with immunomodulatory properties, regulates CD40 gene expression. IFN-beta induces CD40 expression in macrophages and microglia at the transcriptional level, and GAS elements in the CD40 promoter are required for IFN-beta-induced CD40 promoter activity. The critical role of signal transducers and activators of transcription-1alpha (STAT-1alpha) in this response was confirmed by utilizing primary microglia from STAT-1alpha deficient mice. IFN-beta induces suppressor of cytokine signaling-1 (SOCS-1) gene expression, which inhibits cytokine signaling by inhibiting activation of STAT proteins. The ectopic expression of SOCS-1 abrogates IFN-beta-mediated STAT-1alpha activation and inhibits IFN-beta-induced CD40 expression. IFN-beta-induced recruitment of STAT-1alpha and RNA Pol II and permissive histone modifications on the CD40 promoter are also inhibited by SOCS-1 overexpression. These novel results indicate that IFN-beta-induced SOCS-1 plays an important role in the negative regulation of IFN-beta-induced CD40 gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16571771     DOI: 10.1096/fj.05-5493fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  34 in total

1.  A MyD88-JAK1-STAT1 complex directly induces SOCS-1 expression in macrophages infected with Group A Streptococcus.

Authors:  Jinghua Wu; Cuiqing Ma; Haixin Wang; Shuhui Wu; Gao Xue; Xinli Shi; Zhang Song; Lin Wei
Journal:  Cell Mol Immunol       Date:  2014-11-17       Impact factor: 11.530

2.  Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes.

Authors:  Hongwei Qin; Sandrine A Niyongere; Sun Jung Lee; Brandi J Baker; Etty N Benveniste
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

3.  DNA methylation analysis of SOCS1, SOCS3, and LINE-1 in microdissected gingival tissue.

Authors:  Denise C Andia; Aline C Planello; Danielle Portinho; Rodrigo A da Silva; Cristiane R Salmon; Enilson A Sallum; Francisco H Nociti Junior; Ana P de Souza
Journal:  Clin Oral Investig       Date:  2015-04-07       Impact factor: 3.573

4.  Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microglia.

Authors:  D G Walker; A M Whetzel; L-F Lue
Journal:  Neuroscience       Date:  2014-10-05       Impact factor: 3.590

5.  IL-17 enhancement of the IL-6 signaling cascade in astrocytes.

Authors:  Xiangyu Ma; Stephanie L Reynolds; Brandi J Baker; Xingang Li; Etty N Benveniste; Hongwei Qin
Journal:  J Immunol       Date:  2010-03-29       Impact factor: 5.422

6.  Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors.

Authors:  Andrea Worschech; Maciej Kmieciak; Keith L Knutson; Harry D Bear; Aladar A Szalay; Ena Wang; Francesco M Marincola; Masoud H Manjili
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

7.  Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling.

Authors:  Antonio DiGiandomenico; Lukasz S Wylezinski; Jacek Hawiger
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

8.  Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes.

Authors:  Brandi J Baker; Hongwei Qin; Etty N Benveniste
Journal:  Glia       Date:  2008-08-15       Impact factor: 7.452

Review 9.  SOCS1 and SOCS3 in the control of CNS immunity.

Authors:  Brandi J Baker; Lisa Nowoslawski Akhtar; Etty N Benveniste
Journal:  Trends Immunol       Date:  2009-07-28       Impact factor: 16.687

10.  Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.

Authors:  Hongwei Qin; Jessica A Buckley; Xinru Li; Yudong Liu; Thomas H Fox; Gordon P Meares; Hao Yu; Zhaoqi Yan; Ashley S Harms; Yufeng Li; David G Standaert; Etty N Benveniste
Journal:  J Neurosci       Date:  2016-05-04       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.